CTRI/2017/04/008295进行中（未招募）3 期
A Prospective, Randomized, Double blind, Parallel group, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of CGA-7 on the Risk Factors of Obesity
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients who are willing to give written informed consent.
- •2. Patient is willing and able to comply with all trial requirements
- •3. Overweight or obese; BMI between 25-30
排除标准
- •Subjects with BMI >30
- •Cigarette smoker, History of heart, liver and kidney disease, hypertension, pregnancy, lactating, Type 1 diabetes and weight loss medication.
研究者
相似试验
招募中
3 期
A clinical study to assess the potential effect and safety of SUN-CA on the Risk Factors of ObesityCTRI/2017/03/008170Vidya Herbs Pvt Ltd70
已完成
不适用
Clinical study of capsule containing lactobacillus strains in adult women subjects suffering from BacterialVaginosis.CTRI/2015/04/005714Spectrum Clinical Research Pvt Ltd10
尚未招募
3 期
A Clinical Study to assess efficacy and safety of Green-Lipped Mussel Oil on joint health in older adults.CTRI/2024/06/068625Great HealthWorks, Inc.
已完成
不适用
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillatio-I48 Atrial fibrillation and flutterAtrial fibrillation and flutterI48PER-025-07BAYER S.A.,
已完成
3 期
A study comparing the efficacy and safety of once-daily oral rivaroxaban with warfarin for the prevention of stroke and embolism in patients with atrial fibrillation.on-central nervous system systemic embolism in subjects with non-valvular atrial fibrillation.Non-central nervous system systemic embolism in subjects with non-valvular atrial fibrillation.Stroke - IschaemicStrokeACTRN12607000214437Bayer Australia Limited14,269